Dishman Carbogen Amcis Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Net Loss of Dishman Carbogen Amcis reported to Rs 69.92 crore in the quarter ended March 2024 as against net loss of Rs 70.72 crore during the previous quarter ended March 2023. Sales rose 5.84% to Rs 654.71 crore in the quarter ended March 2024 as against Rs 618.56 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 153.45 crore in the year ended March 2024 as against net loss of Rs 29.80 crore during the previous year ended March 2023. Sales rose 8.41% to Rs 2615.77 crore in the year ended March 2024 as against Rs 2412.92 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Welspun Corp Ltd, Ipca Laboratories Ltd, Hindware Home Innovation Ltd and FDC Ltd are among the other losers in the BSE's 'A' group today, 31 May 2024.

Dishman Carbogen Amcis Ltd tumbled 13.34% to Rs 162.4 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 1.66 lakh shares were traded on the counter so far as against the average daily volumes of 46738 shares in the past one month.

Welspun Corp Ltd crashed 8.21% to Rs 551.7. The stock was the second biggest loser in 'A' group.On the BSE, 1.42 lakh shares were traded on the counter so far as against the average daily volumes of 69263 shares in the past one month.

Ipca Laboratories Ltd lost 7.78% to Rs 1152.45. The stock was the third biggest loser in 'A' group.On the BSE, 54033 shares were traded on the counter so far as against the average daily volumes of 9388 shares in the past one month.

Hindware Home Innovation Ltd shed 5.88% to Rs 355.45. The stock was the fourth biggest loser in 'A' group.On the BSE, 16153 shares were traded on the counter so far as against the average daily volumes of 14418 shares in the past one month.

FDC Ltd pared 5.55% to Rs 432.65. The stock was the fifth biggest loser in 'A' group.On the BSE, 12670 shares were traded on the counter so far as against the average daily volumes of 12039 shares in the past one month.

Powered by Capital Market - Live News

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 30 May 2024

Powered by Capital Market - Live News

Dishman Carbogen Amcis announced that the USFDA inspection planned between 04 March 2024 and 08 March 2024 at the company's facility in Bavla, Ahmedabad, was completed on 07 March 2024. No any serious issue was raised during the course for the entire inspection.

With this, the company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the US FDA

Powered by Capital Market - Live News